As of January 22, 2025, bluebird bio (BLUE) has a market cap of $77.486 million USD. According to our data, bluebird bio is ranked No.7879 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $77.49 M |
-4.44%
|
Dec 31, 2024 | $81.08 M |
-69.78%
|
Dec 29, 2023 | $0.27 B |
-80.06%
|
Dec 30, 2022 | $1.35 B |
-30.73%
|
Dec 31, 2021 | $1.94 B |
-64.35%
|
Dec 31, 2020 | $5.45 B |
-50.69%
|
Dec 31, 2019 | $11.05 B |
-11.54%
|
Dec 31, 2018 | $12.49 B |
-44.30%
|
Dec 29, 2017 | $22.43 B |
188.65%
|
Dec 30, 2016 | $7.77 B |
-3.92%
|
Dec 31, 2015 | $8.09 B |
-29.98%
|
Dec 31, 2014 | $11.55 B |
337.18%
|
Dec 31, 2013 | $2.64 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Sangamo Therapeutics
SGMO
|
$0.24 B |
0.000 M
|
USA
|
CRISPR Therapeutics
CRSP
|
$3.77 B |
-0.000 M
|
Switzerland
|
Editas Medicine
EDIT
|
$0.11 B |
0.000 M
|
USA
|
Intellia Therapeutics
NTLA
|
$1.12 B |
0.000 M
|
USA
|
Beam Therapeutics
BEAM
|
$2.19 B |
0.000 M
|
USA
|
REGENXBIO
RGNX
|
$0.38 B |
0.000 M
|
USA
|
uniQure
QURE
|
$0.82 B |
0.000 M
|
Netherlands
|
Rocket Pharmaceuticals
RCKT
|
$1.11 B |
-0.000 M
|
USA
|
Voyager Therapeutics
VYGR
|
$0.30 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Boundless Bio
BOLD
|
$59.32 M |
-0.000 M
|
USA
|
Market Cap | = | BLUE Stock Price | * | BLUE Shares Outstanding |
= | $7.97 | * | 9.72 M | |
= | $77.49 M |